Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab plus P-HDFL in advanced gastric cancer
NCT00384878Phase 2Unknown
- Sponsor
- Far Eastern Memorial Hospital
- Start
- Jun 2006
- Primary completion
- Mar 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetuximab in gastric adenocarcinoma, sponsored by Far Eastern Memorial Hospital. Status: unknown.
02
Drugs
cetuximab
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT00384878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384878.